Core Viewpoint - IMCD N.V. has nominated Floris Lagerwerf as the new Chief Financial Officer (CFO) effective January 2027, succeeding Hans Kooijmans who will retire at the end of December 2026 [1][3]. Group 1: Leadership Transition - Floris Lagerwerf has a strong background within IMCD, having joined the company in 2016 and held various finance roles, including Vice-President Finance & Operations for the Americas since January 2023 [2]. - The Supervisory Board expresses confidence in Floris's capabilities, highlighting his deep understanding of IMCD's business and proven track record in finance and M&A [3]. - Hans Kooijmans will continue to support Floris during the transition period until the end of 2026, emphasizing the importance of internal succession [4]. Group 2: Company Performance and Structure - IMCD reported revenues of EUR 4,728 million in 2024 and employs over 5,100 staff [6]. - The company is listed on Euronext Amsterdam and is part of the Dutch ESG AEX index, recognized for its best ESG practices [6].

Core Insights - IMCD N.V. reported a gross profit growth of 2% to EUR 927 million, with a 5% increase on a constant currency basis, indicating resilience in its financial performance despite challenging macro-economic conditions [3][5] - The company experienced a slight decline in operating EBITA, down 2% to EUR 394 million, but showed a 1% increase on a constant currency basis, reflecting stable operational efficiency [5] - Free cash flow for the first nine months was EUR 284 million, compared to EUR 299 million in the same period of 2024, suggesting a minor decrease in cash generation [5] - Cash earnings per share decreased to EUR 4.16 from EUR 4.67 in the first nine months of 2024, indicating a reduction in profitability per share [5] - IMCD expanded its market presence through six completed acquisitions and signed two additional transactions year to date, enhancing its footprint in key markets [5] Company Strategy - The CEO highlighted the company's focus on cost effectiveness and commercial excellence, which are crucial for navigating ongoing uncertainties in global trade and tariff discussions [3] - The company maintains confidence in its asset-light business model, which is supported by a diverse portfolio and advanced digital and supply chain capabilities [3]

Core Viewpoint - IMCD is set to release its First Nine Months 2025 results on November 6, 2025, at 07:00 am CET, followed by an analyst conference call and webcast at 09:00 am CET [1][2]. Company Overview - IMCD, headquartered in Rotterdam, The Netherlands, is a leading global partner in the distribution and formulation of specialty chemicals and ingredients [3]. - The company emphasizes sustainable value addition to the supply chain and aims to address future business challenges with a focus on partnership and transparency [3]. Financial Performance - In 2024, IMCD reported revenues of EUR 4,728 million and employed over 5,100 individuals [4]. - IMCD N.V.'s shares are traded on Euronext Amsterdam under the symbol IMCD and are included in the Dutch ESG AEX index, recognized for best ESG practices [4].

Core Insights - IMCD N.V. celebrates its 30th anniversary, marking significant growth from its foundation in Rotterdam in 1995 to becoming a global leader in specialty chemicals distribution with over 5,200 employees across 60+ countries [1][2][3] Company Overview - IMCD is recognized as a leading global partner for the distribution and formulation of specialty chemicals and ingredients, emphasizing sustainable value in the supply chain [4] - The company reported revenues of EUR 4,728 million in 2024, and its shares are traded on Euronext Amsterdam, included in the Dutch ESG AEX index [5] Milestones - Key milestones include surpassing €1 billion in revenue in 2011, listing on Euronext Amsterdam in 2014, and strategic acquisitions such as MF Cachat in the US and Signet in India [2][6] - The company has expanded its global presence significantly, with a focus on sustainability initiatives and partnerships [2][6] Leadership and Vision - The current CEO, Marcus Jordan, emphasizes the importance of partnerships and the entrepreneurial spirit that has driven IMCD's success over the past three decades [3] - The leadership transition from founder Piet van der Slikke to Valerie Diele-Braun and later Marcus Jordan marks a new chapter for the company [6]

Core Insights - IMCD N.V. has signed an agreement to acquire 100% of the shares in Tillmanns S.p.A., enhancing its market presence in Italy and unlocking growth potential across industrial and food markets [1][4]. Company Overview - Tillmanns, founded in 1940 and headquartered in Milan, Italy, is a well-established distributor of specialty chemicals, serving key markets such as coatings, construction, food & nutrition, and water treatment [2]. - In 2024, Tillmanns reported annual revenues of approximately EUR 143 million and employs a skilled team of 78 people [3]. Strategic Fit - The acquisition of Tillmanns is a strategic fit for IMCD, as it increases scale and market presence in Italy, complementing IMCD's ambition to deliver value-driven solutions and technical support [4]. - Marcus Jordan, CEO of IMCD, emphasized that Tillmanns brings local expertise, a loyal customer base, and a strong growth platform in industrial, water, and food applications [5]. Financial Performance - IMCD reported revenues of EUR 4,728 million in 2024 and has over 5,100 employees [7].

Core Insights - IMCD N.V. reported a forex adjusted gross profit growth of 7% and EBITA growth of 4% for the first half of 2025, demonstrating resilience in challenging macro-economic conditions [2][4] - The company completed six acquisitions across three regions to enhance its capabilities in core market segments [2][4] - Free cash flow decreased to EUR 173 million from EUR 221 million in the first half of 2024, indicating a decline in cash generation [4] - Cash earnings per share fell to EUR 2.94 from EUR 3.23 in the first half of 2024, reflecting a decrease in profitability per share [4] Financial Performance - Gross profit increased by 5% to EUR 634 million, with a 7% increase on a constant currency basis [4] - Operating EBITA rose by 2% to EUR 275 million, with a 4% increase on a constant currency basis [4] Strategic Developments - The company emphasized its asset-light business model and advanced digital and supply chain capabilities as key strengths for future positioning [2]

Core Viewpoint - IMCD N.V. has announced the acquisition of 100% of the shares in Trichem Healthcare Private Limited, Trichem Lifesciences Limited, and Chemistry & Health FZ LLC, enhancing its portfolio in the life-sciences industry, particularly in active pharmaceutical ingredients [1][4]. Company Overview - IMCD is a global leader in the distribution and formulation of specialty chemicals and ingredients, headquartered in Rotterdam, The Netherlands [5]. - In 2024, IMCD reported revenues of EUR 4,728 million and employed over 5,100 staff [6]. Trichem Overview - Trichem, founded in 1998 and based in Mumbai, India, specializes in supplying high-quality active pharmaceutical ingredients and pharmaceutical intermediates, along with regulatory assistance for the pharmaceutical markets in India [2]. - The company operates with 36 employees and generated annual revenue of approximately INR 1.7 billion (around EUR 18 million) for the financial year ending 31 March 2025, with 33% of this revenue derived from commission income [3]. Strategic Importance - The acquisition is positioned to strengthen IMCD's presence in the Indian market, which is a major supplier of generic drugs globally, and to leverage Trichem's market expertise and industry relationships [4].

Core Insights - IMCD N.V. has signed an agreement to acquire 100% of the shares in TECOM Ingredients S.A. [1] - The acquisition aims to enhance IMCD's presence in the Iberian market and expand its portfolio with complementary ingredients [3] Company Overview - IMCD is a global leader in the distribution and formulation of specialty chemicals and ingredients, headquartered in Rotterdam, The Netherlands [4] - In 2024, IMCD reported revenues of EUR 4,728 million and employed over 5,100 staff [5] TECOM Overview - TECOM, founded in 1996 and based in Molins de Rei, Spain, is a recognized distributor of ingredients and additives for the food industry, with annual revenues of approximately EUR 18 million in 2024 [2][3] - The company specializes in various applications, including savory, bakery, dairy, and health and nutrition products [2] Strategic Implications - The acquisition is expected to open new avenues for growth and enhance value for customers by combining the expertise of both companies [3] - The transaction is subject to customary closing conditions and is anticipated to close in the second quarter of 2025 [3]